Presentations

11:00

HLA-DQ molecular mismatch-derived risk score predicts acute rejection and development of de novo donor-specific antibodies in pediatric liver transplantation

Agostina Arrigone (AR)

Bio Abstract

11:07

Liver transplantation after neoadjuvant TACE in HCC: impact of cone-beam CT on bridging and downstaging strategies assessed by the Metroticket 2.0 model

Sergey Astapovich (RU)

Bio Abstract

11:14

Post-Transplant Lymphoproliferative Disorder in Paediatric Liver Transplantation: A National Centre Experience from New Zealand

Yae Jhee Lee (NZ)

Bio Abstract

11:19

Outcomes of liver transplantation for metabolic dysfunction–associated steatotic liver disease in the United States

Reza Saidi (US)

Bio Abstract

11:24

Perioperative glucose alterations and liver transplantation outcomes: A Mongolian cohort study

Sergelen Orgoi (MN)

Bio Abstract

11:29

The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program from the Paired Program

Sergelen Orgoi (MN)

Bio Abstract

11:34

Establishing a protocol for liver transplantation in unresectable colorectal liver metastases: Preliminary results of an Australian clinical trial

Arsalan Bakhtiar (AU)

Bio Abstract

11:39

Optimal frequency of high-flow hemodiafiltration as a bridging therapy to liver transplantation in patients with acute liver failure in Japan.

Kosei Nakamura (JP)

Bio Abstract

11:44

Efficacy of transarterial radioembolization versus transarterial chemoembolization as bridging therapy to liver transplantation for patients with hepatocellular carcinoma

Arpit Amin (US)

Bio Abstract

11:49

Liver transplantation outcomes in patients with secondary biliary cirrhosis following bile duct injury

Eduardo Massabki (BR)

Bio Abstract